We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
- Authors
Boccardo, Francesco; Rubagotti, Alessandra; Puntoni, Matteo; Guglielmini, Pamela; Amoroso, Domenico; Fini, Angela; Paladini, Giuseppe; Mesiti, Mario; Romeo, Domenico; Rinaldini, Michela; Scali, Simona; Porpiglia, Mauro; Benedetto, Chiara; Restuccia, Nunzio; Buzzi, Franco; Franchi, Roberto; Massidda, Bruno; Distante, Vito; Amadori, Dino; Sismondi, Piero
- Abstract
Tamoxifen, which is actually the gold standard adjuvant treatment in estrogen receptor-positive early breast cancer, is associated with an increased risk of endometrial cancer and other life-threatening events. Moreover, many women relapse during or after tamoxifen therapy because of the development of resistance. Therefore new approaches are required.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 22, p5138
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.04.120